These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 34630377)

  • 41. Susceptibility to SARS, MERS, and COVID-19 from animal health perspective.
    Gautam A; Kaphle K; Shrestha B; Phuyal S
    Open Vet J; 2020 Aug; 10(2):164-177. PubMed ID: 32821661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.
    Khalaj-Hedayati A
    J Immunol Res; 2020; 2020():7201752. PubMed ID: 32695833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human Coronaviruses: Counteracting the Damage by Storm.
    Schoeman D; Fielding BC
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronavirus interactions with the cellular autophagy machinery.
    Miller K; McGrath ME; Hu Z; Ariannejad S; Weston S; Frieman M; Jackson WT
    Autophagy; 2020 Dec; 16(12):2131-2139. PubMed ID: 32964796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.
    Stravalaci M; Pagani I; Paraboschi EM; Pedotti M; Doni A; Scavello F; Mapelli SN; Sironi M; Perucchini C; Varani L; Matkovic M; Cavalli A; Cesana D; Gallina P; Pedemonte N; Capurro V; Clementi N; Mancini N; Invernizzi P; Bayarri-Olmos R; Garred P; Rappuoli R; Duga S; Bottazzi B; Uguccioni M; Asselta R; Vicenzi E; Mantovani A; Garlanda C
    Nat Immunol; 2022 Feb; 23(2):275-286. PubMed ID: 35102342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
    Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune response induced by novel coronavirus infection.
    Sun Y; Zou Y; Wang H; Cui G; Yu Z; Ren Z
    Front Cell Infect Microbiol; 2022; 12():988604. PubMed ID: 36389144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
    Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
    Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
    Kellam P; Barclay W
    J Gen Virol; 2020 Aug; 101(8):791-797. PubMed ID: 32430094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
    Ietto G
    Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Innate immune sensing of coronavirus and viral evasion strategies.
    Kasuga Y; Zhu B; Jang KJ; Yoo JS
    Exp Mol Med; 2021 May; 53(5):723-736. PubMed ID: 33953325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
    Lotfi R; Kalmarzi RN; Roghani SA
    Immunol Res; 2021 Jun; 69(3):213-224. PubMed ID: 33928531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.